Search company, investor...

Predict your next investment

Venture Capital

Investments

5

Portfolio Exits

1

About Frost Group

Frost Group is a Miami based private investment firm, led by Dr. Phillip Frost, that invests in areas of pharmaceuticals, diagnostic devices, medical devices, developmental education and entertainment for children, telecommunications, sports licensing, aviation services, software for seismic data analysis, and new materials for computer chips.

Headquarters Location

306 North Johnson Street

Illinois, 60033,

United States

Want to inform investors similar to Frost Group about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Frost Group News

Frost Ice Bar to open in Faneuil Hall next year

Sep 12, 2012

Are you ready for a frosty brew in an even frostier environment? Boston is about to get its first bar made of ice. Frost Ice Bar is scheduled to open in Faneuil Hall next spring, the company announced today. The venue will be constructed and furnished entirely of ice, which means the indoor temperatures will keep at a shiver-inducing 24 degrees, the Frost Group said in its announcement. "While Boston is traditionally defined by its history and heritage, the city is today brimming with a new energy that supports a trendsetting dining and nightlife scene," Frost Group CEO Cindy Brown said in a statement. "Ice bars around the world have proven to be sensationally popular among a broad range of audiences and we believe Frost Ice Bar will be equally well received in New England." The company said the venue will feature "dramatic ice-sculpted interiors." The news release specifically mentioned the venue would make for an unforgettable night for bachelor and bachelorette parties, family outings or corporate events. It remains to be seen however if local New Englanders will want to spend their non-winter months surrounded by ice.

Frost Group Investments

5 Investments

Frost Group has made 5 investments. Their latest investment was in Zebra Biologics as part of their Unattributed VC on December 12, 2015.

CBI Logo

Frost Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/2/2015

Unattributed VC

Zebra Biologics

$3M

Yes

1

9/11/2012

Series A

Subscribe to see more

$99M

Subscribe to see more

0

2/24/2009

Unattributed

Subscribe to see more

Subscribe to see more

0

8/12/2008

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

0

2/5/2008

Unattributed VC - III

Subscribe to see more

$99M

Subscribe to see more

0

Date

12/2/2015

9/11/2012

2/24/2009

8/12/2008

2/5/2008

Round

Unattributed VC

Series A

Unattributed

Unattributed VC

Unattributed VC - III

Company

Zebra Biologics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$3M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

0

0

0

0

Frost Group Portfolio Exits

1 Portfolio Exit

Frost Group has 1 portfolio exit. Their latest portfolio exit was Universal Space Network on January 30, 2009.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/30/2009

Acquired

$99M

1

Date

1/30/2009

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.